CIZZLE BIOTECHNOLOGY ANNOUNCES GROUNDBREAKING COLLABORATION WITH MOFFITT CANCER CENTER TO ADVANCE EARLY-STAGE LUNG CANCER DETECTION

Contributed by: PR Newswire

Tags

Cizzle-Collab-Moffitt

More Like This

Cizzle Biotechnology announces North American licensing deal to launch revolutionary early lung cancer blood test in 2025

PR Newswire associated0

Zedsen partners with Imperial College Healthcare NHS Trust to clinically validate its novel non-invasive sensing technology

BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®

New Government tech deals boost the business of cancer detection

PR Newswire associated0

Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

PR Newswire associated0

Brainomix and Boehringer Ingelheim Launch Strategic Partnership in Fibrosing Lung Disease

BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC

PR Newswire associated0

'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology